Gold Nanoparticles: Smart Drug Delivery for Modern Medicine

 

Gold nanoparticles (AuNPs) represent a breakthrough in drug delivery, evolving into a highly versatile platform for transporting therapeutic compounds directly to specific sites within the body. For clinicians and investigators, AuNPs offer actionable solutions to many persistent challenges in drug delivery. Their exceptional attributes including nanoscale size, inert biocompatibility, and modular architecture, allow precise tuning of morphology and surface chemistry to meet real clinical needs, such as targeted cytotoxicity and optimized pharmacokinetics. For instance, tailored AuNPs have shown promising results in enhancing doxorubicin delivery to breast cancer tumors, significantly improving drug stability and cellular uptake compared to free drug formulations (Faid et al., 2022, Zhang et al., 2020).

Customizing Gold Nanoparticle Design

What truly sets gold nanoparticles apart is their modular design flexibility. The morphology (be it classic spheres, high-surface-area nanostars, or elongated rods) directly affects in vivo behavior and tissue interactions. Clinical teams can strategically employ nanostar or rod shapes to increase payload capacity and take advantage of photothermal properties for targeted cancer cell ablation. As an example, gold nanorods utilized in localized photothermal therapy have demonstrated deep tissue penetration and precise tumor destruction in preclinical models (Tailor et al., 2022). This tunability facilitates combination therapies, offering greater control over treatment efficacy and side effect profiles.

Precision Through Surface Coatings

The surface chemistry of AuNPs is equally critical. Coatings such as polyethylene glycol (PEG) enhance colloidal stability and extend circulation time, which importantly improves accumulation in target tissues (Brown et al., 2010). Surface functionalization with tumor-specific antibodies or peptides has allowed precise nanoparticle homing, which has been demonstrated in experimental glioblastoma treatments where antibody-conjugated AuNPs significantly increased tumor uptake and reduced off-target toxicity (Liangxiao et al., 2021). Such strategy reduces systemic exposure, supporting dose optimization and enhancing patient safety (Si et al, 2025).

Intelligent Drug Incorporation and Release

Gold nanoparticles accommodate a broad spectrum of drug types, from cytotoxic agents like doxorubicin to antibiotics and anti-inflammatories, owing to their adaptable loading and release mechanisms. Drugs can be conjugated chemically or physically encapsulated within engineered shells. Moreover, controlled release triggered by tumor-specific stimuli such as pH changes or enzymatic activity has been successfully demonstrated in preclinical settings. For example, studies indicate programmed release of chemotherapeutics from AuNPs in acidic tumor microenvironments, optimizing therapeutic index while minimizing systemic toxicity (George et al., 2020, Park et al, 2019). This capability aligns naturally with personalized medicine approaches and clinical protocol demands.

Transforming Cancer Therapy and Beyond

Gold nanoparticles are actively raising clinical standards in oncology. The combination of morphology optimization and surface engineering enables selective chemotherapy delivery with reduced side effects. Clinical and preclinical studies reflect enhanced treatment outcomes, positioning AuNP-based platforms as leading candidates in next-generation cancer therapeutics (Alalmaie et al., 2025). Additionally, AuNPs show promise in anti-infective therapies by enabling high local drug concentrations and diminishing resistance risks. Ongoing research continues to refine these features based on patient and disease-specific variables, promising further integration into precision medicine frameworks across therapeutic areas.

By leveraging tailored nanoparticle design,  adaptable surface chemistry, and intelligent drug loading, gold nanoparticles offer a robust, precision toolkit addressing the most demanding challenges in modern drug delivery. They stand as a cornerstone technology for advancing personalized and effective therapeutic strategies (Georgeous, et al., 2024, Mitchell et al., 2021, Huang et al., 2023).

References

  1. Faid, A. H., Shouman, S. A., Badr, Y. A., & Sharaky, M. (2022). Enhanced cytotoxic effect of doxorubicin conjugated gold nanoparticles on breast cancer model. BMC chemistry, 16(1), 90. https://doi.org/10.1186/s13065-022-00889-9
  2. Zhang, C., Zhang, F., Han, M. et al. (2020) Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer. Sci Rep 10, 22015 (2020). https://doi.org/10.1038/s41598-020-79125-0
  3. Taylor, M. L., Wilson, R. E., Jr., Amrhein, K. D., & Huang, X. (2022). Gold Nanorod-Assisted Photothermal Therapy and Improvement Strategies. Bioengineering, 9(5), 200. https://doi.org/10.3390/bioengineering9050200
  4. Brown S.D., Nativo P., Smith J.A. et al. (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc.132:4678–4684. https://doi.org/10.1021/ja908117a
  5. Liangxiao, W., Shengnan, T., Yawen, Yu et al.(2021) Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Molecular Pharmaceutics 18 (3), 915. https://doi.org/10.1021/acs.molpharmaceut.0c00911
  6. Si, J., Liu, Z., Gu, F., Jin, X., & Ma, Y. (2025) Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review). International Journal of Oncology, 67, 83. https://doi.org/10.3892/ijo.2025.5789
  7. George, T.R., Poilil, S.S., and Yeon, J.Y. (2020) Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy. Frontiers in Molecular Bioscience, 7. https://doi.org/10.3389/fmolb.2020.610533
  8. Park, S., Lee, W.J., Park, S. et al. (2019) Reversibly pH-responsive gold nanoparticles and their applications for photothermal cancer therapy. Sci Rep 9, 20180. https://doi.org/10.1038/s41598-019-56754-8
  9. Alalmaie A, et al. (2025) Integrating computational insights in gold nanoparticle-mediated drug delivery: enhancing efficacy and precision. Frontiers in Medical Technology, https://doi.org/10.3389/fmedt.2025.1528826
  10. Georgeous, J., AlSawaftah, N., Abuwatfa, W. H., & Husseini, G. A. (2024). Review of Gold Nanoparticles: Synthesis, Properties, Shapes, Cellular Uptake, Targeting, Release Mechanisms and Applications in Drug Delivery and Therapy. Pharmaceutics, 16(10), 1332. https://doi.org/10.3390/pharmaceutics16101332  
  11. Mitchell, M.J., Billingsley, M.M., Haley, R.M. et al. (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20, 101–124. https://doi.org/10.1038/s41573-020-0090-8
  12. Huang, H., Liu, R., Yang, J., Dai, J., Fan, S., Pi, J., Wei, Y., & Guo, X. (2023). Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy. Pharmaceutics, 15(7), 1868. https://doi.org/10.3390/pharmaceutics15071868

      Back to Gold Applications